Seattle startup raises $9.7M for clinical trial to test inhaled CBD as anxiety treatment by Charlotte Schubert on April 7, 2022April 7, 2022 at 12:00 pm Seattle startup Receptor Life Sciences has raised $9.7 million to move its CBD-based therapeutic candidate for acute anxiety through clinical testing. The company is developing a dry powdered form of… Read More